Biocon Biologics Ltd, a fully integrated global biosimilars company and a unit of Biocon Ltd, has obtained the US Food and Drug Administration (FDA) approval for their denosumab biosimilars
Since its injectable medication Stelara, which generated over $10 billion in sales last year, is up against fierce competition from less expensive competitors, J&J has been developing more practical psoriasis treatment choices
India's pharmaceutical industry is set to record healthy revenue growth of 7-9 per cent in FY26, even as challenges in the United States market continue to weigh on performance, noted rating agency ICRA in its latest sector outlook
Elsevier has revealed a comprehensive AI platform for researchers to reshape how academic and corporate sectors conduct work. The goal of this advanced platform is to empower scientists to transition quickly from insights to real-world...
Bayer announced the launch of Bayer Co.Lab AdVenture, a major extension of their global life sciences incubator network meant to connect biotechnological startups with vanguard venture capital firms worldwide.
one of the largest private sector healthcare services companies in India, and Medtronic, a global leader in healthcare technology
ZyVet Animal Health, a part of Zydus Pharmaceuticals (USA), and the leader in affordable generic animal medicines, has just announced the debut of the first FDA-approved generic phenylpropanolamine hydrochloride tablets.
Mankind Pharma joins hands with OpenAI to embed advanced AI across its value chain, transforming sales, R&D, manufacturing, and healthcare innovation.
Cadila Pharmaceuticals, research-driven pharmaceutical company, one of the best in India, has launched Nu Nutridac, a clinically validated dietary supplement specially designed to relieve the patients
Dr Reddy's Laboratories has revealed that the India launch of Tegoprazan (50 mg) will be available shortly. It is a new generation potassium-competitive acid blocker (P-CAB) created to treat acid-related gastrointestinal disorders.